Liquid chromatographic tandem mass spectrometric determination of trandolapril in human plasma

Analytica Chimica Acta

Volumn 540, Issue 2, 2005, Pages 375-382

  Pistos, Constantinos ^a   Koutsopoulou, Maria ^a   Panderi, Irene ^b  

^a Independent Research and Laboratory Solutions (ILS)   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Human plasma; Tandem mass spectrometry; Trandolapril

Indexed keywords

ACETONITRILE; CONCENTRATION (PROCESS); EXTRACTION; IONIZATION; MASS SPECTROMETRY; REACTION KINETICS;

HUMAN PLASMA; MOBILE PHASE; MULTIPLE-REACTION MONITORING (MRM) MODES; TRANDOLPRIL;

LIQUID CHROMATOGRAPHY;

ACETIC ACID; ACETONITRILE; BLOOD EXTRACT; LISINOPRIL; TRANDOLAPRIL; TRIETHYLAMINE;

ANALYTIC METHOD; ARTICLE; BLOOD PUMP; BLOOD SAMPLING; CALIBRATION; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ION MONITORING; LINEAR SYSTEM; PARTICLE SIZE; POSITIVE ION ELECTROSPRAY; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

EID: 18844373654     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aca.2005.03.052     Document Type: Article

References (24)

1. M.R. Weir, J.M. Gray, R. Paster, and E. Saunders Hypertension 26 1995 124
2. D.R.P. Guay Clin. Ther. 25 3 2003 713
3. A. Sigurdsson, S.V. Eriksson, C. Hall, T. Kahan, and K. Swedberg Eur. J. Heart Fail. 3 1 2001 69
4. G. Steiner, and N.C. Pauly J. Cardiovasc. Pharmacol. 23 4 1994 81
5. A. Patat, A. Surius, A. LeGo, and J. Granier Eur. J. Clin. Pharmacol. 36 1989 17
6. F. De Ponti, C. Marelli, L. D'Angelo, M. Caravaggi, L. Bianco, S. Lecchini, G.M. Frigo, and A. Crema Eur. J. Clin. Pharmacol. 40 1991 149
7. F.J. Lopez-Hernandez, O. Flores, J.M. Lopez-Novoa, M.J. Montero, and R.J. Carron J. Cardiovasc. Pharmacol. 32 2 1998 284
8. N. Genes, G. Lemoine, A. Duguet, L. Vaur, G. Moreau, C. Etrillard, and F. Soullier Therapie 50 2 1995 131
9. I. Cedrowska, K. Bankowski, and J. Iskra-Jopa ActaPol. Pharm. 60 2 2003 141
10. J.C. Song, and C.M. White Clin. Pharmacokin. 41 3 2002 207
11. M. Hirayama, A. Kurihara, T. Manabe, and Y. Hasegawa Drug Metab. Dispos. 22 4 1994 601
12. B. Danielson, S. Querin, P. LaRochelle, E. Sultan, M. Mouren, T. Bryce, J.P. Stepniewski, and B. Lenfant J. Cardiovasc. Pharmacol. 23 4 1994 50
13. P. Arner, A. Wade, P. Engfeldt, M. Mouren, J.P. Stepniewski, E. Sultan, T. Bryce, and B. Lenfant J. Cardiovasc. Pharmacol. 23 4 1994 44
14. B. Lenfant, M. Mouren, T. Bryce, D. De Lauture, and G. Strauch J. Cardiovasc. Pharmacol. 23 4 1994 38 43
15. A. Gumieniczek, and H. Hopkala Acta Pol. Pharm. 57 4 2000 253
16. M. Jemal, M. Huang, Y. Mao, D. Whigan, and A. Schuster Rapid Commun. Mass Spectrom. 14 2000 1023
17. A. Tsakalof, K. Bairachtari, and M. Georgarakis J. Chromatogr. B 782 2003 425
18. W. Xiao, B. Chen, S. Yao, and Z. Cheng J. Chromatogr. B 814 2 2005 314
19. A.A.F. Padua, R.E. Barrientos-Astigarraga, V.M. Rezende, G.D. Mendes, and G. De Nucci J. Chromatogr. B 809 2. 2004 211 216
20. W.F. Smvth Anal. Chim. Acta 492 2003 1
21. C. Pistos, M. Koutsopoulou, and I. Panderi Anal. Chim. Acta 514 2004 15
22. W.M.A. Niessen Liquid Chromatography-Mass Spectrometry. Chromatographic Science Series vol. 79 1999 Marcel Dekker 405 459 (Chapter 13)
23. Committee for proprietary medicinal products, note for guidance on the investigation of bioavailability and bioequivalence, London, 1998.
24. ICH Topic Q2B. Pharmaeurop 8 (1996) 108.